The Budetec TM900v2 for tumor volume calculation is the flagship result of our commitment to innovative instrumentation for scientists, researchers, and engineers. (TM900v2)

Designed for academic institutions, R&D centers, and industry, this advanced system reflects over 25 years of expertise in measurement and imaging system development. By integrating our experience in software, electronic, and mechanical engineering with strategic business development and a global sales network, Budetec transforms complex customer needs into state-of-the-art biomedical research instruments.

A key highlight of this expertise is the Budetec TM900v2, designed for accurate, automated tumor volume calculation. Following Budetec’s 2022 global acquisition of the original TM900 (tumorvolume.com), we engineered the upgraded TM900v2—an innovative, non-invasive, subcutaneous tumor volume measurement instrument designed to precisely track and monitor tumor growth in mice models.

By combining technical innovation with strategic growth, Budetec continues to advance cutting-edge biomedical technology for oncology research